Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma

Conditions: Large B-cell Lymphoma Interventions: Drug: Golcadomide; Drug: Placebo; Drug: Rituximab; Drug: Cyclophosphamide; Drug: Doxorubicin; Drug: Vincristine; Drug: Prednisone Sponsors: Celgene Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials